Dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer

Major pathological response (MPR) is a potential surrogate for overall survival. We determined whether the dynamic changes in (18)F‐labeled fluoro‐2‐deoxyglucose positron emission tomography/computed tomography ((18)F‐FDG PET/CT) were associated with MPR in patients receiving neoadjuvant immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhi‐Yong, Fu, Rui, Tan, Xiao‐Yue, Yan, Li‐Xu, Tang, Wen‐Fang, Qiu, Zhen‐Bin, Qi, Yi‐Fan, Li, Yu‐Fa, Hou, Qing‐Yi, Wu, Yi‐Long, Zhong, Wen‐Zhao, Jiang, Ben‐Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436661/
https://www.ncbi.nlm.nih.gov/pubmed/35822254
http://dx.doi.org/10.1111/1759-7714.14562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436661/
https://www.ncbi.nlm.nih.gov/pubmed/35822254
http://dx.doi.org/10.1111/1759-7714.14562

Ejemplares similares